Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. J of Skin. 2019;3:S2. doi:10.25251/skin.3.supp.2